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INTRODUCTION
The Na+-K+-Clco-transport system is a secondary active inward C1-transport system which exploits the Na+ electrochemical gradient to drive C1-into, for example, cardiac cells and smooth muscle [l, 21. There are suggestions that there is an anomaly in co-transport in primary hypertension (see [l] ), and our evidence is that, in the rat deoxycorticosterone acetate (DOCA)/salt model of hypertension, co-transport is more active in arterial smooth muscle, resulting in an elevated [Cl-]i. Consequently, the chloride equilibrium potential (EcI) is less negative in hypertension, and this contributes to the depolarized membrane potential (Em) observed in this condition [3, 41. The idea is, therefore, that the lower E m will make the muscle more prone to contract, and thus contribute to the generation and maintenance of hypertension.
There are, in fact, three processes by which C1-is transported into rat arterial smooth muscle. One is Na+-K+-Clco-transport and another is Cl-/HC03-exchange, but this is not functional in the HC03--free media [5] in which the experiments just described were carried out. The third is an entity we call 'pump 111' which is not dependent on Na+ or HC03-and which is inhibited by acetazolamide [6, 71. There was reason to suspect that a then unknown C1-transport system was activated in hypertension in addition to Na+-K+-CIco-transport [4] , and the purpose of this study is to find out whether this system is, in fact, 'pump 111'. A preliminary account has been published [8] .
METHODS
Male Sprague-Dawley rats (150-400 g; Bantin & Kingman, Hull, U.K.) were used, and the means of induction, maintenance and monitoring of the development of DOCA/salt hypertension were as described previously [3, 41. All procedures were carried out in accordance with the provisions of the Animals (Scientific Procedures) Act, 1986 (U.K.).
Recordings of E m and intracellular chloride ([Cl-]i) in isolated femoral arterial smooth muscle were made using double-barrelled chloride-sensitive microelectrodes [4] . The muscle was superfused at 37°C by an oxygenated physiological salt solution containing (in mmol/l): Na+ 140, K+ [4] ). All values of [Cl-]i are given as concentration (mmol/l) and are corrected for intracellular interference, which was found to be 4 mmol/l in normotension [9] and in this study in hypertension. Inhibitors were added to the superfusion reservoir at the concentrations indicated.
All values are given as mean J. SD (n = number of observations), and statistical analysis was done using unpaired Student's &tests in Microsoft Excel. The target significance was P<O.OOl.
RESULTS

Blood pressure, [Cl-]i, co-transport and Em in hypertension
The arterial systolic blood pressure rose linearly with time as DOCA/salt hypertension developed, and [Cl-li in femoral arterial smooth muscle also increased linearly with time up to 6 weeks post-operative (Fig. 1) . The increase in [Cl-]i was significant (P<O.OOOl) and it was originally attributed to an increase in Na+-K+-Cl-co-transport activity. This was because 10 pmol/l bumetanide, a specific inhibitor of co-transport at this concentration, caused a larger hyperpolarization [3] and a greater fall in [Cl-]i in hypertension than in normotension [4] . The actions of bumetanide were confirmed in the present study by testing its effect on muscle isolated from unoperated controls and on 5-6week postoperative hypertensive animals ( Fig. 2 and Table 1 (Table 1) . Moreover, Emin hypertension (-56.1 f2.3 mV, n = 9) was less negative than in normotension ( -64.3 k4.4 mV, n = 16, P<O.OOOl), again in accord with previous work [3, 41.
Effect of acetazolamide in normotension and hypertension
In normotension, when 1 mmol/l acetazolamide (the 'pump 111' inhibitor) and 10 pmol/l bumetanide were both present, [Cl-]i fell to 13mmol/l (Fig. 2 , Table 1 ). This was in exact agreement with the calculated equilibrium value at the observed E m of -66.1 f2.0 mV (n = 7). In hypertension under the same conditions, [Cl-]i fell similarly to 15 mmol/l, which is not measurably different from the calculated equilibrium value of 14 mmol/l at the measured E m of -63.1 f2.4 mV (n = 9). Thus acetazolamide caused a significantly greater fall in [Cl-]i in hypertension (16 mmol/l) than in normotension (7 mmol/l) and, in the presence of bumetanide and acetazolamide, there was no significant difference between either [Cl-li in normotension and hypertension (P > 0.07) or E m (P > 0.008). (n = 39) and, in hypertension -60.4 f 3.6 mV (n = 26). Thus, there is no significant difference.
DISCUSSION
The main conclusion is that the increase in [Cl-]i in rat arterial smooth muscle in the DOCA/salt model of hypertension is due to the activation of two inwardly directed C1-transport systems. One, as shown previously [3, 41, is the well known Na+-K+-Cl-co-transport system and the other is an entity which we call 'pump 111' [6, 71. The amount by which the two transport systems are activated in hypertension cannot be exactly estimated from these experiments. However, the C1-permeability is not changed in hypertension (A.A. Harper, J.P.L. Davis and A.R. Chipperfield, unpublished work) and therefore it appears that the activity of (7) 14.7f1.7(9) 7.4 f 2.9 15.8 f 2.5 both transport systems very roughly doubles. If there is a difference in activation of the two transport systems, then it is 'pump 111' which shows greater activation.
Since the rationale of the investigation is that the depolarizing influence of [Cl-]i is more prominent in hypertension [3, 41, it follows that 'pump III', as well as co-transport, has a depolarizing influence on E m in hypertension. Therefore, at least in the experimental model of hypertension used here, [Cl-]i may play a role in the development of hypertension, and there are three lines of evidence which bear out this contention. First, in the absence of C1-, the membrane potential was the same in normotension and hypertension. This must indicate that C1-is important in the depolarization of E m in hypertension. Secondly, there was a clear parallel between the linear increases in blood pressure and [Cl-]i (Fig. 1) and, whilst the time resolution is not very precise, there must be a relationship if [Cl-]i, Emand blood pressure are linked in the way that is suggested. Thirdly, the regime for the induction of hypertension requires that the animals are given solutions of 1% NaC1/0.2% KCI to drink. If, however, the animals are given CI--free (or Na+-free) solutions to drink, then the evidence in the literature is that DOCA/salt hypertension either does not develop or is greatly attenuated [lo, 111. This suggests that in this experimental situation C1-, no less than Na+, has an important role in the development of hypertension.
The reasons why the activities of co-transport and 'pump 111' increase in hypertension is unknown, and there is also the possibility that the kidney might be involved. Thus, up-regulation of Na+-K+-Clco-transport in the kidney would lead to volume expansion and hence hypertension [12] and, whilst there is no direct evidence that 'pump 111' occurs in the kidney, a C1-transport system which is inhibited by ethacrynic acid with a very steep concentration dependence, which is characteristic of 'pump IIi' [7] , does occur in the cortical thick ascending limb in rabbit kidney [13] .
In conclusion, during the development of DOCAI salt hypertension in the rat, two inward C1-transport systyems are activated in arterial smooth muscle. Whether these transport systems cause the blood pressure to rise, via the depolarizing influence of [Cl-] i on E m in arterial smooth muscle, is not certain. On the other hand, there is compelling evidence that C1-plays an essential role in the development of DOCAhalt hypertension, although the idea that C1-is important in hypertension is not new (L. Ambard and E. Beaujard, 1904; cited in [101)-
